Q1 2025 · 13F-HR
PURA VIDA INVESTMENTS, LLCholdings as filed
Filed 2025-05-12 · accession 0001590144-25-000003
$13.7M
Reported value
8
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 08659B102 | BBNX | BETA BIONICS INC | $5.3M | 38.4% | 429,120 | Common | SOLE |
| 68235C206 | IMDX | ONCOCYTE CORP | $2.9M | 21.2% | 947,134 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $1.8M | 13.4% | 45,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $1.2M | 8.85% | 450,517 | Common | SOLE |
| G52441105 | KMTS | KESTRA MED TECHNOLOGIES LTD | $996,800 | 7.28% | 40,000 | Common | SOLE |
| 690145206 | OM | OUTSET MED INC | $783,417 | 5.72% | 5,000 | Common | SOLE |
| 59102M104 | MGX | METAGENOMI INC | $359,572 | 2.63% | 264,391 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $353,525 | 2.58% | 2,500 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.